A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors von DEMETRI, George D, CASALI, Paolo G, PINK, Daniel, DEBIEC-RYCHTER, Maria, WING CHEUNG, BAILEY, Stuart M, LUISA VERONESE, Maria, REICHARDT, Annette, FUMAGALLI, Elena, REICHARDT, Peter, BLAY, Jean-Yves, VON MEHREN, Margaret, MORGAN, Jeffrey A, BERTULLI, Rossella, RAY-COQUARD, Isabelle, CASSIER, Philippe, DAVEY, Monica, BORGHAEI, Hossein

Volltext

Mechanisms of Hypertension Associated With BAY 43-9006 von VERONESE, Maria Luisa, MOSENKIS, Ari, FLAHERTY, Keith T, GALLAGHER, Maryann, STEVENSON, James P, TOWNSEND, Raymond R, O'DWYER, Peter J

Volltext

The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer von Sozzi, Gabriella, Veronese, Maria Luisa, Negrini, Massimo, Baffa, Raffaele, Cotticelli, Maria Grazia, Inoue, Hiroshi, Tornielli, Silvana, Pilotti, Silvana, De Gregorio, Laura, Pastorino, Ugo, Pierotti, Marco A, Ohta, Masataka, Huebner, Kay, Croce, Carlo M

Volltext

Identification of a Gene at 11q23 Encoding a Guanine Nucleotide Exchange Factor: Evidence for Its Fusion with MLL in Acute Myeloid Leukemia von Kourlas, Peter J., Strout, Matthew P., Becknell, Brian, Veronese, Maria Luisa, Croce, Carlo M., Theil, Karl S., Krahe, Ralf, Ruutu, Tapani, Knuutila, Sakari, Bloomfield, Clara D., Caligiuri, Michael A.

Volltext

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations von Hyman, David M, Puzanov, Igor, Subbiah, Vivek, Faris, Jason E, Chau, Ian, Blay, Jean-Yves, Wolf, Jürgen, Raje, Noopur S, Diamond, Eli L, Hollebecque, Antoine, Gervais, Radj, Elez-Fernandez, Maria Elena, Italiano, Antoine, Hofheinz, Ralf-Dieter, Hidalgo, Manuel, Chan, Emily, Schuler, Martin, Lasserre, Susan Frances, Makrutzki, Martina, Sirzen, Florin, Veronese, Maria Luisa, Tabernero, Josep, Baselga, José

Volltext

Pemigatinib in previously treated solid tumors with activating FGFR1–FGFR3 alterations: phase 2 FIGHT-207 basket trial von Rodón, Jordi, Damian, Silvia, Furqan, Muhammad, García-Donas, Jesús, Imai, Hiroo, Italiano, Antoine, Spanggaard, Iben, Ueno, Makoto, Yokota, Tomoya, Veronese, Maria Luisa, Oliveira, Natalia, Li, Xin, Gilmartin, Aidan, Schaffer, Michael, Goyal, Lipika

Volltext

Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1–FGFR3 alterations: phase 2 FIGHT-207 basket trial von Rodón, Jordi, Damian, Silvia, Furqan, Muhammad, García-Donas, Jesús, Imai, Hiroo, Italiano, Antoine, Spanggaard, Iben, Ueno, Makoto, Yokota, Tomoya, Veronese, Maria Luisa, Oliveira, Natalia, Li, Xin, Gilmartin, Aidan, Schaffer, Michael, Goyal, Lipika

Volltext

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view von Le Tourneau, Christophe, André, Fabrice, Helland, Åslaug, Mileshkin, Linda, Minnaard, Warnyta, Schiel, Anja, Taskén, Kjetil, Thomas, David M., Veronese, Maria Luisa, Durán-Pacheco, Gonzalo, Leyens, Lada, Rufibach, Kaspar, Thomas, Marlene, Krämer, Alwin

Volltext

A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement von Vannucchi, Alessandro M., Patel, Jay L., Shomali, William E., George, Tracy I., Reiter, Andreas, Rambaldi, Alessandro, Oh, Stephen, Usuki, Kensuke, Harrison, Claire N., Luisa Veronese, Maria, Gilmartin, Aidan, Zhen, Huiling, Verstovsek, Srdan, Oliveira, Natalia, Gotlib, Jason, Kiladjian, Jean-Jacques

Volltext

MPN-384 A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement von Vannucchi, Alessandro M., Patel, Jay L., Shomali, William E., George, Tracy I., Reiter, Andreas, Rambaldi, Alessandro, Oh, Stephen, Usuki, Kensuke, Harrison, Claire N., Luisa Veronese, Maria, Gilmartin, Aidan, Zhen, Huiling, Verstovsek, Srdan, Oliveira, Natalia, Gotlib, Jason, Kiladjian, Jean-Jacques

Volltext

A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement von Vannucchi, Alessandro M., Patel, Jay L., Shomali, William E., George, Tracy I., Reiter, Andreas, Rambaldi, Alessandro, Oh, Stephen, Usuki, Kensuke, Harrison, Claire N., Luisa Veronese, Maria, Gilmartin, Aidan, Zhen, Huiling, Verstovsek, Srdan, Oliveira, Natalia, Gotlib, Jason, Kiladjian, Jean-Jacques

Volltext

Monoclonal antibodies in the treatment of colorectal cancer von Veronese, Maria Luisa, O'Dwyer, Peter J.

Volltext

VE-BASKET, a first-in-kind, phase II, histology-independent “basket” study of vemurafenib (VEM) in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m) von Hyman, David Michael, Blay, Jean-Yves, Chau, Ian, Raje, Noopur S., Fernandez, Maria Elena Elez, Wolf, Juergen, Sirzen, Florin, Veronese, Maria Luisa, Mitchell, Lada, Puzanov, Igor, Baselga, Jose

Volltext

VE-BASKET, a Simon 2-stage adaptive design, phase II, histology-independent study in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m): Activity of vemurafenib (VEM) w... von Tabernero, Josep, Chan, Emily, Baselga, Jose, Blay, Jean-Yves, Chau, Ian, Hyman, David Michael, Raje, Noopur S., Wolf, Juergen, Sirzen, Florin, Veronese, Maria Luisa, Mitchell, Lada, Hidalgo, Manuel

Volltext

The Efficacy of Vemurafenib in Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Preliminary Results from VE-Basket Study von Hyman, David M., Diamond, Eli, Subbiah, Vivek, Blay, Jean-Yves, Lockhart, A. Craig, Abdel-Wahab, Omar, Sirzen, Florin, Veronese, Maria Luisa, Laserre, Susan Frances, Elez, Elena, Baselga, Jose

Volltext

Open-label, multicenter safety study of vemurafenib in patients with BRAF V600 mutation–positive metastatic melanoma von Larkin, James M. G., Del Vecchio, Michele, Ascierto, Paolo Antonio, Schachter, Jacob, Garbe, Claus, Neyns, Bart, Mandala, Mario, Lorigan, Paul, Miller, Wilson H, Guminski, Alexander David, Berking, Carola, Rutkowski, Piotr, Queirolo, Paola, Hauschild, Axel, Arance, Ana Maria, Brown, Michael Paul, Mitchell, Lada, Veronese, Maria Luisa, Blank, Christian U.

Volltext

FHIT Gene Alterations in Head and Neck Squamous Cell Carcinomas von Virgilio, Laura, Shuster, Michele, Gollin, Susanne M., Veronese, Maria Luisa, Ohta, Masataka, Huebner, Kay, Croce, Carlo M.

Volltext

Structure and expression of the human FHIT gene in normal and tumor cells von DRUCK, T, HADACZEK, P, ROTHSTEIN, J, MCCUE, P, COTTICELLI, M. G, INOUE, H, CROCE, C. M, HUEBNER, K, FU, T.-B, OHTA, M, SIPRASHVILI, Z, BAFFA, R, NEGRINI, M, KASTURY, K, VERONESE, M. L, ROSEN, D

Volltext

An open-label, multicenter safety study of vemurafenib (PLX4032, RO5185426) in patients with metastatic melanoma von Larkin, James M. G., Queirolo, Paola, Arance, Ana M, Brown, Michael Paul, Hauschild, Axel, Del Vecchio, Michele, McArthur, Grant A., Neyns, Bart, Becker, Jürgen C., Hansson, Johan, Hogg, David, Ascierto, Paolo Antonio, Loquai, Carmen, Espinosa, Enrique, Garbe, Claus, Patel, Poulam M, Schachter, Jacob, Mitchell, Lada, Veronese, Maria Luisa, Blank, Christian U.

Volltext

Loss of FHIT expression in gastric carcinoma von BAFFA, R, VERONESE, M. L, SANTORO, R, MANDES, B, PALAZZO, J. P, RUGGE, M, SANTORO, E, CROCE, C. M, HUEBNER, K

Volltext